CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 Edwards Lifesciences - EW CFD

79.32
2.78%
0.23
最低: 79.31
最高: 81.63
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.23
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Edwards Lifesciences Corp ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 81.59
开盘价* 81.53
1 年变化* -26.78%
日范围* 79.31 - 81.63
52 周范围 67.13-131.10
平均交易量（10 天） 4.47M
平均交易量（3 个月) 73.00M
市值 49.32B
市盈率 33.25
流通股 608.31M
收入 5.38B
EPS 2.44
股息（收益率 %） N/A
贝塔 1.02
下一个财报发布日期 Apr 24, 2023

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 21, 2023 81.59 0.59 0.73% 81.00 82.33 80.63
Mar 20, 2023 80.93 0.79 0.99% 80.14 81.60 79.74
Mar 17, 2023 80.60 -0.59 -0.73% 81.19 82.47 80.07
Mar 16, 2023 81.75 3.75 4.81% 78.00 82.14 77.86
Mar 15, 2023 79.38 2.90 3.79% 76.48 79.40 76.42
Mar 14, 2023 78.02 0.90 1.17% 77.12 78.15 76.27
Mar 13, 2023 76.49 3.17 4.32% 73.32 76.92 73.00
Mar 10, 2023 74.24 -1.46 -1.93% 75.70 75.78 73.78
Mar 9, 2023 75.94 -1.12 -1.45% 77.06 78.03 75.78
Mar 8, 2023 77.13 0.21 0.27% 76.92 77.33 75.83
Mar 7, 2023 78.81 0.39 0.50% 78.42 79.91 78.32
Mar 6, 2023 78.68 -1.99 -2.47% 80.67 81.19 78.41
Mar 3, 2023 81.76 0.83 1.03% 80.93 82.05 80.47
Mar 2, 2023 80.12 1.19 1.51% 78.93 80.72 78.83
Mar 1, 2023 79.77 0.08 0.10% 79.69 79.96 78.57
Feb 28, 2023 80.37 3.57 4.65% 76.80 80.88 76.80
Feb 27, 2023 77.21 0.80 1.05% 76.41 78.27 76.41
Feb 24, 2023 76.11 0.00 0.00% 76.11 77.08 75.74
Feb 23, 2023 77.46 2.13 2.83% 75.33 77.57 75.33
Feb 22, 2023 75.31 -0.21 -0.28% 75.52 76.45 75.24

Edwards Lifesciences Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 5232.5 4386.3 4348 3722.8 3435.3
收入 5232.5 4386.3 4348 3722.8 3435.3
收入成本，共计 1248.9 1080.6 1114.4 939.4 875.3
毛利 3983.6 3305.7 3233.6 2783.4 2560
总营业费用 3542.2 3488.7 3201.2 2967.5 2400.4
销售/一般/行政费用，总计 1493.7 1228.4 1240.2 1088.5 985.8
研究与开发 903.1 760.7 752.7 622.2 552.6
利息费用（收入) - 净运营 -1.6
异常费用（收入） 20.6 405.4 100 323.1 -13.4
Other Operating Expenses, Total -124.1 13.6 -6.1 -5.7 1.7
营业收入 1690.3 897.6 1146.8 755.3 1034.9
税前净收入 1702 916.7 1166.5 761.4 1034.9
税后净收入 1503.1 823.4 1049.7 738 877.7
未计算非常项目前的净收益 1503.1 823.4 1049.7 738 877.7
净收入 1503.1 823.4 1046.9 722.2 583.6
普通股股东可获收益 (不含非经常性项目) 1503.1 823.4 1049.7 738 877.7
普通股股东可获收益 (含非經常性項目) 1503.1 823.4 1046.9 722.2 583.6
摊薄净收入 1503.1 823.4 1046.9 722.2 583.6
摊薄后加权平均股 631.2 631.9 636.606 640.806 647.706
扣除特别项目的每股摊薄盈利 2.38134 1.30305 1.6489 1.15167 1.35509
每股正常摊薄盈利 2.41016 1.87932 1.79025 1.64039 1.33754
非常规项目总计 -2.8 -15.8 -294.1
利息收入（费用），非经营净值 9.8 20.5 21.3 17.3
其他，净值 1.9 -1.4 -1.6 -11.2
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 1341.2 1329.7 1310.2 1376 1216.6
收入 1341.2 1329.7 1310.2 1376 1216.6
收入成本，共计 299.3 309.5 311.7 334.3 293.4
毛利 1041.9 1020.2 998.5 1041.7 923.2
总营业费用 902.4 955.3 919.9 833.9 833.1
销售/一般/行政费用，总计 370.3 424 364.4 374.5 330.8
研究与开发 228.6 232.8 238 225.3 207
异常费用（收入） 7.1 7.1 4.7 2.4 6.4
Other Operating Expenses, Total -2.9 -18.1 1.1 -102.6 -4.5
营业收入 438.8 374.4 390.3 542.1 383.5
利息收入（费用），非经营净值 -4 1.6 0.4 3.1 4.7
其他，净值 1.3 0.3 0.2 0.3 1.1
税前净收入 436.1 376.3 390.9 545.5 389.3
税后净收入 373.6 335.3 340.1 489.5 338.2
未计算非常项目前的净收益 373.6 335.3 340.1 489.5 338.2
净收入 373.6 335.3 340.1 489.5 338.2
普通股股东可获收益 (不含非经常性项目) 373.6 335.3 340.1 489.5 338.2
普通股股东可获收益 (含非經常性項目) 373.6 335.3 340.1 489.5 338.2
摊薄净收入 373.6 335.3 340.1 489.5 338.2
摊薄后加权平均股 629.4 631.8 631.7 629.9 631.3
扣除特别项目的每股摊薄盈利 0.59358 0.53071 0.53839 0.77711 0.53572
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 0.60325 0.54072 0.54486 0.78053 0.54453
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 3180.7 3091 2984 2286.9 2549.2
现金和短期投资 1466.8 1402.6 1516.9 956.5 1337.5
现金等价物 862.8 1183.2 1179.1 714.1 818.3
短期投资 604 219.4 337.8 242.4 519.2
应收账款总额，净额 664.9 602.8 599.1 537.3 479.3
Accounts Receivable - Trade, Net 582.2 514.6 543.6 456.9 438.7
Total Inventory 726.7 802.3 640.9 607 554.9
Prepaid Expenses 85.2 75.1 59.1 54.3 60.6
Other Current Assets, Total 237.1 208.2 168 131.8 116.9
Total Assets 8502.6 7237.1 6488.1 5323.7 5666.4
Property/Plant/Equipment, Total - Net 1638.7 1489.4 1140.4 867.5 679.7
Goodwill, Net 1167.9 1173.2 1167.7 1112.2 1126.5
Intangibles, Net 323.6 331.4 336.5 343.2 468
Long Term Investments 1834.2 801.6 585.5 506.3 567
Other Long Term Assets, Total 357.5 350.5 274 207.6 276
Total Current Liabilities 1032.3 893.9 902.4 876.6 1420
Accounts Payable 204.5 196.5 180.4 134 116.6
Accrued Expenses 714.2 578.7 642.7 510.2 516.1
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 113.6 118.7 79.3 232.4 189.3
Total Liabilities 2666.7 2662.8 2339.8 2183.3 2710.2
Total Long Term Debt 595.7 595 594.4 593.8 438.4
Long Term Debt 595.7 595 594.4 593.8 438.4
Other Liabilities, Total 779.7 959.5 671.3 588 851.8
Total Equity 5835.9 4574.3 4148.3 3140.4 2956.2
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 642 636.4 218.1 215.2 212
Additional Paid-In Capital 1700.4 1438.1 1623.3 1384.4 1166.9
Retained Earnings (Accumulated Deficit) 6068.1 4565 3741.6 2694.7 1962.1
Treasury Stock - Common -2416.9 -1904.1 -1278.7 -1015.4 -252.1
Other Equity, Total -150.8 -169.7 -157.7 -133.5 -128.1
Total Liabilities & Shareholders’ Equity 8502.6 7237.1 6488.1 5323.7 5666.4
Total Common Shares Outstanding 624.1 624.3 627.306 623.106 629.106
Current Port. of LT Debt/Capital Leases 0 0 0 598
Unrealized Gain (Loss) -6.9 8.6 1.7 -5 -4.6
Property/Plant/Equipment, Total - Gross 2293.3 2087.9 1652.7 1322.8
Accumulated Depreciation, Total -654.6 -598.5 -512.3 -455.3
Deferred Income Tax 259 214.4 171.7 124.9
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 3241.3 3180.7 3515.5 3322.9 3069.2
现金和短期投资 1495.9 1466.8 1794.7 1561.2 1330.6
现金等价物 1030.9 862.8 1506.9 1312.8 1174.2
短期投资 465 604 287.8 248.4 156.4
应收账款总额，净额 686.2 664.9 664.2 700.3 664.3
Accounts Receivable - Trade, Net 636.3 582.2 600.6 640.5 586.6
Total Inventory 730.6 726.7 737.8 759.5 767.9
Prepaid Expenses 94.1 85.2 76.9 68.6 77.3
Other Current Assets, Total 234.5 237.1 241.9 233.3 229.1
Total Assets 8419.9 8502.6 8160.3 7662.1 7213.7
Property/Plant/Equipment, Total - Net 1642.3 1638.7 1549.4 1530.4 1506.4
Goodwill, Net 1166.3 1167.9 1170.4 1171.8 1170.8
Intangibles, Net 322 323.6 325.3 327 330.3
Long Term Investments 1623.7 1834.2 1282 1014.2 802.2
Other Long Term Assets, Total 424.3 357.5 317.7 295.8 334.8
Total Current Liabilities 949.9 1032.3 966.5 886.2 799
Accounts Payable 158.8 204.5 139.5 144.6 150.4
Accrued Expenses 615.9 714.2 721.7 634.7 546.9
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 175.2 113.6 105.3 106.9 101.7
Total Liabilities 2575 2666.7 2619 2528.8 2555.3
Total Long Term Debt 595.9 595.7 595.5 595.4 595.2
Long Term Debt 595.9 595.7 595.5 595.4 595.2
Deferred Income Tax 270.7 259 245.4 234.2 224.2
Other Liabilities, Total 758.5 779.7 811.6 813 936.9
Total Equity 5844.9 5835.9 5541.3 5133.3 4658.4
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 642.9 642 641.2 640.1 637.5
Additional Paid-In Capital 1769.4 1700.4 1643.1 1578.7 1496.8
Retained Earnings (Accumulated Deficit) 6441.7 6068.1 5732.8 5392.7 4903.2
Treasury Stock - Common -2822.5 -2416.9 -2320.4 -2318.6 -2206.7
Unrealized Gain (Loss) -39.2 -6.9 3 4.8 4.7
Other Equity, Total -147.4 -150.8 -158.4 -164.4 -177.1
Total Liabilities & Shareholders’ Equity 8419.9 8502.6 8160.3 7662.1 7213.7
Total Common Shares Outstanding 621.4 624.1 624.2 623.1 621.8
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 1503.1 823.4 1046.9 722.2 583.6
经营活动产生的现金 1732.1 1054.3 1179.4 926.8 1000.7
经营活动产生的现金 134.8 107.2 89.3 77.4 81.9
Deferred Taxes -41.4 -49.4 12.1 -27.3 17.8
非现金物品 -9.7 130.9 235.4 197.1 83.2
Cash Taxes Paid 182.5 197.9 61.5 223.7 143.7
已付现金利息 20.2 19.9 19.9 30.1 19.9
营运资金的变化 145.3 42.2 -204.3 -42.6 234.2
投资活动产生的现金 -1722.5 -531.1 -595.8 76.7 -647.2
资本支出 -329.8 -407.3 -278.4 -241.7 -175.5
其他投资现金流量项目，总计 -1392.7 -123.8 -317.4 318.4 -471.7
融资活动产生的现金 -356.3 -486.9 -115.6 -1101.2 -473.2
融资现金流项目 -0.3 -1.2 -2.8 -15.4 0
股票的发行（报废），净额 -354.2 -484.9 -102.8 -648.5 -649.5
债务的发行（退还），净额 -1.8 -0.8 -10 -437.3 176.3
外汇效应 13.9 -20.5 -3 -6.5 7.9
现金净变化 -332.8 15.8 465 -104.2 -111.8
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 373.6 1503.1 1167.8 827.7 338.2
Cash From Operating Activities 293.3 1732.1 1358.5 826.6 300.5
Cash From Operating Activities 34.7 134.8 101.8 68.2 32.4
Deferred Taxes -42.6 -41.4 20.1 16.2 10.8
Non-Cash Items 57 -9.7 -15.8 -47.5 28.3
Changes in Working Capital -129.4 145.3 84.6 -38 -109.2
Cash From Investing Activities 229.5 -1722.5 -756.6 -379.2 -49.7
Capital Expenditures -72.7 -329.8 -236 -175.3 -106
Other Investing Cash Flow Items, Total 302.2 -1392.7 -520.6 -203.9 56.3
Cash From Financing Activities -368.1 -356.3 -294.3 -333.3 -274.3
Financing Cash Flow Items 0 -0.3 -1 -3 -2.9
Issuance (Retirement) of Stock, Net -368.1 -354.2 -291.6 -328.7 -271
Issuance (Retirement) of Debt, Net 0 -1.8 -1.7 -1.6 -0.4
Foreign Exchange Effects 13.2 13.9 12.1 11.6 14.2
Net Change in Cash 167.9 -332.8 319.7 125.7 -9.3
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.4282 51269903 639997 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3695 32663343 1051645 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.488 27301166 493844 2022-12-31 LOW
Capital International Investors Investment Advisor 3.7385 22741986 44526 2022-12-31 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 3.6146 21988324 4770672 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.5105 15271736 624619 2022-12-31 LOW
Brown Advisory Investment Advisor/Hedge Fund 2.3575 14341102 115268 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9951 12136243 205714 2022-12-31 LOW
Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 1.811 11016774 -647534 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4506 8824423 2342600 2022-12-31 LOW
Fisher Investments Investment Advisor/Hedge Fund 1.2613 7672618 133880 2022-12-31 LOW
Sands Capital Management, LLC Investment Advisor 1.2356 7516085 -2889817 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 1.0808 6574509 4084454 2022-12-31 HIGH
BlackRock Asset Management Ireland Limited Investment Advisor 0.9468 5759351 129517 2022-12-31 LOW
Nuveen LLC Pension Fund 0.8833 5373020 -65227 2022-12-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.7864 4783540 -652308 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.7454 4534155 2227180 2022-12-31 HIGH
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7446 4529198 -237259 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7156 4353305 8792 2022-12-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 0.7115 4328367 473547 2022-12-31 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Edwards Lifesciences Company profile

关于 Edwards Lifesciences

Edwards Lifesciences公司是一家心脏瓣膜系统和修复产品的制造商，用于替换或修复病人患病或有缺陷的心脏瓣膜。 该公司从事以病人为中心的结构性心脏病和重症监护的创新工作。 它的分部包括美国、欧洲、日本和世界其他地区。 其产品和技术分为四个主要领域。 经导管主动脉瓣置换术、经导管二尖瓣和三尖瓣治疗术、外科结构性心脏病和重症监护。 该公司还开发了血液动力学和无创的脑和组织氧饱和度监测系统，用于在医院环境中测量病人的心血管功能。 Edwards SAPIEN系列瓣膜，包括Edwards SAPIEN XT、Edwards SAPIEN 3和Edwards SAPIEN 3 Ultra经导管主动脉心脏瓣膜，用于治疗心脏瓣膜疾病。

Industry: Advanced Medical Equipment & Technology (NEC)

One Edwards Way
92614

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,567.80 Price
-1.370% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 3.0

XRP/USD

0.43 Price
-13.310% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00371

BTC/USD

27,448.55 Price
-2.650% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Gold

1,969.99 Price
+1.510% 1D Chg, %
多头隔夜费 -0.0086%
空头隔夜费 0.0004%
隔夜费时间 21:00 (UTC)
价差 0.30

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易